http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104027597-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_75916237f86ee0b6b383d4d7009b4dcc |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-8984 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-62 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 |
| filingDate | 2014-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_447ef9e43f65cfe909c400f559ae4a7b |
| publicationDate | 2014-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104027597-A |
| titleOfInvention | Traditional Chinese medicine for treating qi-deficiency and blood-stasis syndrome type thromboangiitis obliterans |
| abstract | The invention discloses a traditional Chinese medicine for treating qi-deficiency and blood-stasis syndrome type thromboangiitis obliterans, which is characterized by being prepared from the following medicinal materials in parts by weight: 50 parts of astragalus membranaceus, 50 parts of codonopsis pilosula, 30 parts of rose, 8 parts of rubus reflexus, 25 parts of Chinese angelica, 25 parts of root of common peony, 25 parts of the root of red-rooted salvia, 25 parts of the root of bidentate achyranthes, 25 parts of bighead atractylodes rhizome, 50 parts of dendrobe, 15 parts of resina draconis, 15 parts of forged natural copper, 20 parts of pangolin, 20 parts of leech, and 10 parts of liquorice. The traditional Chinese medicine prepared according to the formula disclosed by the invention is capable of effectively improving blood circulation, adjusting blood distribution, smoothing microcirculation disturbance, improving local tissue hypoxia state and solving vasospasm and thrombolysis, therefore, qi-deficiency and blood-stasis syndrome type thromboangiitis obliterans is effectively treated; and in addition, found from application of 40 patients, the effective rate is up to 95% for years. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105902734-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104784335-A |
| priorityDate | 2014-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 70.